Daljeet Kohli’s good luck at finding winning stocks appears to have returned. Another one of his stock picks is a mega-bagger in just over a year
Posts tagged Aurobindo Pharma
Rakesh Jhunjhunwala Gives Green Signal That Bombed-Out Realty Sector Is Bottoming Out & Time Is Ripe For us To Buy Beaten Down Stocks
Rakesh Jhunjhunwala, the Badshah of Dalal Street, is a multi-billionaire today because of his superb sense of timing and mastery of stock picking. He has sent all of us the clarion call that the beleaguered realty sector is close to bottoming out and that the time is ripe for us to gently start loading on to these stocks
Rakesh Jhunjhunwala’s Fav Pharma Stock Is An 8-Bagger In Just 24M. It Is On Everyone’s Buy List Now!
Rakesh Jhunjhunwala’s sheer mastery in stock picking goes unnoticed by the hoi polloi because the Badshah maintains a dignified silence and does not tom-tom his achievements. However, we need to pay tribute to the Badshah because he is an inspiration to us that we can also achieve similar success if we walk on his path
Rahul Arora Pockets 200% Gain From Top-Quality FMCG Stock. Promises 200% More Gains
Rahul Arora’s stock pick has a stellar track record of consistent growth & high ROE. It has a huge potential for growth and is available at reasonable valuations. He has already raked in a mega gain of 200% from the stock and foresees more bumper gains from the stock
Three Stock Picks Of Daljeet Singh Kohli
Daljeet Singh Kohli of IndiaNivesh has discussed three of his favourite stocks
The Stock Picks Of Ravi Dharamshi Of ValueQuest
Ravi Dharamshi Of ValueQuest has discussed his favourite stocks in a chat with ETNow
Will Rakesh Jhunjhunwala’s latest Healthcare Stock Pick Be A Multi-Bagger Like Lupin & Aurobindo?
Rakesh Jhunjhunwala holds a formidable stake in the Pharma & Healthcare sector in the form of Lupin & Aurobindo Pharma. His latest stock pick is a mid-cap with top-quality management, strong brand image and ambitious growth plans
Daljeet Kohli Previews Q3FY15 Results Of Top Pharma Companies
Daljeet Kohli of IndiaNivesh has issued a comprehensive report previewing the Q3FY15 results of 18 pharma companies and given clear-cut buy, sell and hold recommendations
Daljeet Kohli Rakes In Mega Bucks From Favourite Stocks. He Promises More Gains For Us In 2015
Daljeet Kohli has been on a winning streak in 2014. His winning stocks outnumber his losing stocks by a wide margin. He has promised more gains for us in 2015
Aurobindo Pharma Has Immense Potential To Grow: Sharekhan
Sharekhan has issued a research report claiming that the the acquisition of Natrol is a positive development for Aurobindo Pharma and that the stock should be bought
Recent Comments